Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection

Blood

Volumn 90, Issue 10, 1997, Pages 3865-3873

  Casato, Milvia ^a   Agnello, Vincent ^a   Pucillo, Leopoldo P ^a   Knight, Glenn B ^a   Leoni, Marco ^a   Del Vecchio, Savino ^a   Mazzilli, Cristina ^a   Antonelli, Guido ^a   Bonomo, Lorenzo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; HLA DR3 ANTIGEN; INTERFERON;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GENE MUTATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; SYSTEMIC VASCULITIS;

EID: 0030733477     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.10.3865     Document Type: Article

References (49)

1. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N: Cryoglobulinemia-A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 40:837, 1966
2. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M: Biologic and clinical significance of cryoglobulins: A report of 86 cases. Am J Med 57:775, 1974
3. Agnello V, Romain PL: Mixed cryoglobulinemia secondary to hepatitis C virus infection. Rheum Dis Clin North Am 22:1, 1996
4. Agnello V, Chung RT, Kaplan LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490, 1992
5. Bonomo L, Casato M, Afeltra A, Caccavo D: Treatment of idiopathic mixed cryoglobulinemia with alpha Interferon. Am J Med 83:726, 1987
6. Casato M, Lagana B, Antonelli G, Dianzani F, Bonomo L: Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia. Blood 78:3142, 1991
7. Knox TA, Hillyer CD, Kaplan MM, Berkman EM: Mixed cryoglobulinemia responsive to interferon-alpha (letter). Am J Med 91:554, 1991
8. Geltner D: Therapeutic approaches in mixed cryoglobulinemia. Springer Semin Immunopathol 10:103, 1988
9. St Clair WE: Vasculitis, in Weisman MH, Weinblatt ME (eds): Treatment of the Rheumatic Diseases: Companion to the Textbook of Rheumatology. Philadelphia, PA, Saunders, 1995, p 137
10. Davis GL, Lau JY, Lim HL: Therapy for chronic hepatitis C. Gastroenterol Clin North Am 23:603, 1994
11. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C: Mutations in the nonstructural protein 5A gene and response to Interferon in patients with chronic hepatitis C virus lb infection. N Engl J Med 334:77, 1996
12. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19:1513, 1994
13. Casato M, Antonelli G, Maggi F, Pucillo LP, Di Lullo L, Leoni M, Currenti M, Dianzani F, Bonomo L: Resistance to recombinant alpha interferon therapy in idiopathic mixed cryoglobulinemia: Reinduction of remission by natural alpha interferon both in antibody-positive and -negative patients. J Biol Regul Homeost Agents 8:56, 1994
14. Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225, 1992
15. Agnello V, Barnes JL: Human rheumatoid factor cross-idiotypes. I. WA and BLA are heat-labile conformational antigens requiring both heavy and light chains. J Exp Med 164:1809, 1986
16. Cha TA, Beall E, Irvine B, Kolberg J, Chien D, Kuo G, Urdea MS: At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci USA 89:7144, 1992
17. Widell A, Shev S, Mansson S, Zhang YY, Foberg U, Norkrans G, Fryden A, Weiland O, Kurkus J, Nordenfelt E: Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: Epidemiological applications. J Med Virol 44:272, 1994
18. Agnello V, Zhang QX, Abel G, Knight GB: The association of hepatitis C virus infection with monoclonal rheumatoid factors bearing the WA cross-idiotype: Implications for the etiopathogenesis and therapy of mixed cryoglobulinemia. Clin Exp Rheumatol 13:5101, 1995
19. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 108:157, 1995
20. Nightingale SD, Pelley RP, Delaney NL, Bias WB, Hamburger MI, Fries LF, Steinberg AG: Inheritance of mixed cryoglobulinemia. Am J Hum Genet 33:735, 1981
21. Migliorini P, Bombardieri S, Castellani A, Ferrara GB: HLA antigens in essential mixed cryoglobulinemia. Arthritis Rheum 24:932, 1981
22. Berliner S, Weinberger A, Zamir R, Hazaz B, Pinkhas J: Familial cryoglobulinemia and C4 deficiency. Scand J Rheumatol 13:151, 1984
23. Agnello V: The aetiology of mixed cryoglobulinaemia associated with hepatitis C virus infection. Scand J Immunol 42:179, 1995
24. Durand JM, Kaplanski G, Lefevre P, Richard MA, Andrac L, Trepo C, Soubeyrand J: Effect of interferon-alpha 2b on cryoglobulinemia related to hepatitis C virus infection (letter). J Infect Dis 165:778, 1992
25. Ferri C, Marzo E, Longobardo G, Lombardini F, La Civita L, Vanacore R, Liberati AM, Gerli R, Greco F, Moretti A, Monti M, Gentilini P, Bombardieri S, Zignego AL: Interferon-alpha in mixed cryoglobulinemia patients: A randomized, crossover-controlled trial. Blood 81:1132, 1993
26. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, Zilio P, Vernocchi A, Massazza M, Vendramin G, Tanzi E, Zanetti A: Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330:751, 1994
27. Dammacco F, Sansonno D, Han JH, Shymala V, Cornacchiulo V, Iacobelli AR, Lauletta G, Rizzi R: Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: A long-term, randomized, controlled study. Blood 84:3336, 1994
28. Kasahara A, Hayashi N, Hiramatsu N, Oshita M, Hagiwara H, Katayama K, Kato M, Masuzawa M, Yoshihara H, Kishida Y, Shimizu Y, Inoue A, Fusamoto H, Kamada T: Ability of prolonged Interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial. Hepatology 21:291, 1995
29. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, Couzigou P, Payen JL, Sajus M, Costa JM, Vidaud M, Chaput JC, and the multicenter study group: A comparison of three Interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 332:1457, 1995
30. Vilcek J, Sen GC: Interferons and other cytokines, in Fields BN, Knipe DM, Howley PM (eds): Fields Virology. Philadelphia, PA, Lippincott, 1996, p 375
31. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, Vendramin G, Comotti B, Tanzi E, Scudeller G, Zanetti A: Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 117:573, 1992
32. Chemello L, Cavalletto D, Pontisso P, Bortolotti F, Donda C, Donadon V, Frezza M, Casarin P, Alberti A: Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease. Hepatology 17:179, 1993
33. Nasoff MS, Zebedee SL, Inchauspe G, Prince AM: Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc Natl Acad Sci USA 88:5462, 1991
34. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C, Missale G, Marin MG, Fiaccadori F: T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19:286, 1994
35. Zanella A, Conte D, Prati D, Mozzi F, Capelli C, Zanuso F, Fraquelli M, Bosoni P, Vianello L, Pappalettera M, Velio P, Montagnolo G, Bianchi PA, Sirchia G: Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay. Hepatology 21:913, 1995
36. Botarelli P, Brunetto MR, Minrtello MA, Calvo P, Unutmaz D, Weiner AJ, Choo QL, Shuster JR, Kuo G, Bonino F, Houghton M, Abrignani S: T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 104:580, 1993
37. Yuki N, Hayashi HN, Hagiwara H, Takehara T, Katayama K, Kasahara A, Fusamoto H, Kamada T: Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy. Hepatology 17:960, 1993
38. Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde A, Pietrogrande M, Renoldi P, Bombardier S, Bordin G, Candela M, Ferri C, Gabrielli A, Mazzaro C, Migliaresi S, Mussini C, Ossi E, Quintiliani L, Tirri G, Vacca A, and the GISC: Cryoglobulinaemias: A multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. Q J Med 88:115, 1995
39. Agnello V, Zhang QX, Elfahal M, Abel G, Knight G: Association of hepatitis C virus (HCV) with VLDL in type II cryoglobulinemia. Ninth International Congress of Immunology, San Francisco, CA, July 23-29, 1995, p 631
40. Agnello V, Abel G, Zhang QX, Elfahal M, Knight GB: Low density lipoprotein receptor mediated endocytosis of hepatitis C virus. IX Triennial International Symposium on Viral Hepatitis and Liver Disease, Rome, Italy, April 21-25, 1996, p 158
41. Bukh J, Miller RH, Purcell RH: Genetic heterogeneity of hepatitis C virus: Quasispecies and genotypes. Semin Liver Dis 15:41, 1995
42. Zeuzem S, Schmidt JM, Lee JH, Rster B, Roth WK: Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo. Hepatology 23:366, 1996
43. Willems M, Sheng L, Roskams T, Ramdani B, Doutrelepont JM, Neven F, Durez P, Treille S, Adler M, Desmet V, Fevery J, Yap SH: Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia-related syndrome. J Med Virol 44:266, 1994
44. Pozzato G, Mazzaro C, Crovatto M, Modolo ML Ceselli S, Mazzi G, Sulfaro S, Franzin F, Tulissi P, Moretti M, Santini GF: Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 84:3047, 1994
45. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia MB, Andre C, Voisin MC, Intrator L, Zafrani ES, Duval J, Dhumeaux D: Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 122:169, 1995
46. Mazzaro C, Tulissi P, Moretti M, Mazzoran L, Pussini E, Crovatto M, Santini GF, Pozzato G: Clinical and virological findings in mixed cryoglobulinaemia. J Intern Med 238:153, 1995
47. Sinico RA, Ribero ML, Fornasieri A, Renoldi P, Zhou J, Fasola M, Portera G, Arrigo G, Gibelli A, D'Amico G, Tagger A: Hepatitis C virus genotype in patients with essential mixed cryoglobulinaemia. Q J Med 88:805, 1995
48. Zignego AL, Ferri C, Giannini C, Monti M, La Civita L, Careccia G, Longobardo G, Lombardini F, Bombardier S, Gentilini P: Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 124:31, 1996
49. Andonov A, Chaudhary RK: Genotyping of Canadian hepatitis C virus isolates by PCR. J Clin Microbiol 32:2031, 1994